论文信息 - Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features - 字舞流文

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features

D. Galetta | S. Novello | F. de Marinis | D. Giannarelli | E. Bria | E. Vita | A. Gelibter | V. Stati | A. Passaro | M. Reale | S. Carnio | Alessio Stefani | I. Attili | P. Pizzutilo | A. Stefani | M. L. Reale